Central Institute of Mental Health, Mannheim
78
11
14
46
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.5%
9 terminated/withdrawn out of 78 trials
83.6%
-2.9% vs industry average
10%
8 trials in Phase 3/4
2%
1 of 46 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (78)
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
Role: collaborator
XR2ESILIENCE - XR-Based Resilience Training for Stress and Mental Health in Healthcare Workers
Role: collaborator
Brain Signal Training to Enhance Affect Down-regulation
Role: lead
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Role: lead
Enhancing Recovery in Early Schizophrenia
Role: lead
A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence
Role: lead
Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
Role: lead
Selective Attention in Alcohol Use Disorder
Role: lead
Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Role: lead
Chess Training as add-on Intervention for Adolescents With Psychiatric and Psychosomatic Disorders
Role: lead
Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder
Role: lead
Validation of a Training Program for Patients With Alcohol Use Disorder
Role: lead
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
Role: lead
Electroconvulsive Therapy for Treatment of Alzheimer´s Disease
Role: lead
Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment
Role: lead
Evaluation Study of New Compounds With Potential Use in Schizophrenia
Role: lead
Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study
Role: lead
Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation
Role: lead
Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption
Role: lead
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Role: lead